As of the latest SEC filings, POSEIDA THERAPEUTICS INC (PSTX) is held by 6 institutional funds. The largest fund shareholder is BlackRock Advantage Small Cap Core Fund (BDSKX), holding an estimated $153,298.54 in market value, representing a significant portion of its portfolio.
Funds holding POSEIDA THERAPEUTICS INC (PSTX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- PSTX
- CIK:
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
BDSKX
BlackRock Advantage Small Cap Core Fund
|
MF | BlackRock / iShares | 0.00% | $153,298.54 | 104,999 | Feb 27, 2026 | Apr 24, 2026 |
|
GDL
GDL Fund
|
CEF | Independent / Boutique | 0.02% | $20,898.50 | 41,797 | Mar 31, 2026 | Jun 1, 2026 |
|
PSGIX
BlackRock Advantage Small Cap Growth Fund
|
MF | BlackRock / iShares | 0.00% | $12,621.70 | 8,645 | Mar 31, 2026 | May 26, 2026 |
|
MRSPX
BlackRock Advantage SMID Cap Fund, Inc.
|
MF | BlackRock / iShares | 0.00% | $6,832.80 | 4,680 | Mar 31, 2026 | May 26, 2026 |
|
GADVX
The Gabelli ABC Fund
|
MF | GAMCO / Gabelli | 0.00% | $4,000.00 | 8,000 | Mar 31, 2026 | Jun 1, 2026 |
|
EMACX
Enterprise Mergers and Acquisitions Fund
|
MF | GAMCO / Gabelli | 0.00% | $2,250.00 | 4,500 | Mar 31, 2026 | Jun 1, 2026 |
Advertisement (320x50)